A CASE REPORT ON AYURVEDIC MEDICINE (RED MERCURIC SULPHATE) INDUCED BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA (BOOP) IN SERO POSITIVE RHEUMATOID PATIENT
Keywords:
Bronchiolitis obliterans and organizing pneumonia (BOOP), Rasasindhoora, Mercuric sulphate, Rheumatoid arthritisAbstract
Bronchiolitis obliterans organizing pneumonia (BOOP) is a lung disease that causes inflammation in the small air tubes (bronchioles) and air sacs (alveoli). It can be caused due to wide range of etiologies like viral infections, various drugs, chemicals, and other medical conditions. A 55 y old female patient presented with symptoms of BOOP who had a history for taking ayurvedic medicine (rasasindura–red mercuric sulphate) for rheumatoid arthritis. The patient didn't respond to initial symptomatic therapy and the reports of High-resolution computed tomography (HRCT) and chest X ray revealed the diagnosis as drug induced BOOP. In search of etiologies mercuric sulphate (major ingredient of rasasindura–ayurvedic medicine) was confirmed among all other possible etiologies. Patient was advised to discontinue ayurvedic medicine and completely cured by treatment with steroids for 2 mo. She didn't show any symptoms of relapse in 3 mo observation period.
Â
Downloads
References
Alghanemsara, Aljahdalihamdan, Bamefleh Hanaa, Khan Ali Nawaz. Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy review. Ann Thorac Med 2008;3:67-75.
Horton, Mark J Hamblin, Maureen R. Rheumatoid Arthritis-Associated Interstitial Lung Disease: Diagnostic Dilemma. Pulmonary Medicine; 2011.
Juanmanuel, Lisa Diethelm, Luis A. Ortiz. Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum 1995;24:242–54.
Kajiya T, Kuroda A, Hokonohara D, Tei C. Radiographic appearance of bronchiolitis obliterans organizing pneumonia (BOOP) developing during Bucillamine treatment for rheumatoid arthritis. Am J Med Sci 2006;332:39-42.
Ulubaş B, Sahin G, Ozer C, Aydin O, Ozgür E, Apaydin D. Bronchiolitis obliterans organizing pneumonia associated with sulfasalazine in a patient with rheumatoid arthritis. Clin Rheumatol 2004;23:249-51.
Young Ho Lee1, Ye Ree Kim, Jong Dae Ji, Jae Jeong Shim, Kyung Ho Kang, Ju Han Lee, et al. A case of BOOP developed during bucillamine treatment for rheumatoid. Korean J Intern Med 2001;16:36-9.
KL Soeken, SA Miller, E Ernst. Herbal medicines for the treatment of rheumatoid arthritis: a systematic review. Rheumatology 2003;42:652–9.
Biswaj Y, Rohit G. Research works done on rasasindura (sublimated mercurial preparation)-a critical review. Ayurpharmint J Ayuralli Sci 2014;13:41-7.
Christopher V, Tehlirian MD. Rheumatoid lung disease. Rheumatology Rounds Online; 2011. Available from: http://www.hopkinsarthritis.org/physician-corner/rheumatology-rounds/round-16-rheumatoid-lung-disease. [Last accessed on 05 Jun 2015].
Watanabe K, Senju S, Maeda F, Yshida M. Four cases of bronchiolitis obliterans organizing pneumonia associated with thyroid disease. Respiration 2000;67:572-6.
Egerer G, Witzens M, Spaeth A, Breitbart A, Möller P, Goldschmidt H, et al. Successful treatment of bronchiolitis obliterans organizing pneumonia with low-dose methotrexate in a patient with Hodgkin's disease. Oncology 2001;61:23-7.
Masoodur R, Rayhan H, Said A. Quinine induced bronchiolitis obliterans and organizing pneumonia. J Anaesthesiol Clin Pharmacol 2012;28:505–7.
Ryland PB, Zab M. Drug induced pulmonary toxicity. Medscape reference; 2014.
S Verma, V Mahajan. Drug induced pulmonary diseases. Internet journal of pulmonary medicine; 2007.
Glezos JD, Albrecht JE. Pneumonitis after inhalation of mercury vapours. Can Respir J 2006;13:150-2.